Lantern Pharma Inc. SEC filings LTRN
Lantern Pharma Inc. has 262 filings in SEC EDGAR's recent list, going back to Jan 14, 2019. Its latest annual report, Form ARS, was filed on Oct 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 18, 2026 | — |
| D | Filing | May 21, 2026 | — |
| EFFECT | Filing | Jun 10, 2024 | — |
| CORRESP | Letter to the SEC | Jun 6, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2024 | — |
| EFFECT | Filing | Jul 12, 2021 | — |
| CORRESP | Letter to the SEC | Jul 8, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2021 | — |
| EFFECT | Filing | Jan 14, 2021 | — |
| CORRESP | Letter to the SEC | Jan 11, 2021 | — |
| CORRESP | Letter to the SEC | Jan 8, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2020 | — |
| DRS | Filing | Dec 16, 2020 | — |
| DRSLTR | Filing | Dec 15, 2020 | — |
| SEC STAFF LETTER | Filing | Jun 16, 2020 | — |
| EFFECT | Filing | Jun 10, 2020 | — |
| CERT | 8a cert | Jun 8, 2020 | — |
| CORRESP | Letter to the SEC | Jun 8, 2020 | — |
| CORRESP | Letter to the SEC | Jun 8, 2020 | — |
| 8-A12B | For registration of certain classes | Jun 8, 2020 | — |
| CORRESP | Letter to the SEC | Jun 2, 2020 | — |
| UPLOAD | Letter from the SEC | May 29, 2020 | — |
| CORRESP | Letter to the SEC | May 22, 2020 | — |
| UPLOAD | Letter from the SEC | May 22, 2020 | — |
| CORRESP | Letter to the SEC | May 12, 2020 | — |
| UPLOAD | Letter from the SEC | May 1, 2020 | — |
| CORRESP | Letter to the SEC | Apr 16, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 21, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 21, 2020 | — |
| DRSLTR | Filing | Jan 24, 2020 | — |
| DRS | Filing | Jan 24, 2020 | — |
| D | Filing | Mar 18, 2019 | — |
| D | Filing | Jan 14, 2019 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LTRN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Dallas, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1763950
- Former names
- Lantern Pharma (until Jan 14, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.